1174 related articles for article (PubMed ID: 33347618)
1. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
[TBL] [Abstract][Full Text] [Related]
2. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006105. PubMed ID: 25406011
[TBL] [Abstract][Full Text] [Related]
3. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
[TBL] [Abstract][Full Text] [Related]
5. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046
[TBL] [Abstract][Full Text] [Related]
6. Inositol for subfertile women with polycystic ovary syndrome.
Showell MG; Mackenzie-Proctor R; Jordan V; Hodgson R; Farquhar C
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012378. PubMed ID: 30570133
[TBL] [Abstract][Full Text] [Related]
7. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.
Georgiou EX; Melo P; Baker PE; Sallam HN; Arici A; Garcia-Velasco JA; Abou-Setta AM; Becker C; Granne IE
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31747470
[TBL] [Abstract][Full Text] [Related]
8. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Morley LC; Tang T; Yasmin E; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003053. PubMed ID: 29183107
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
[TBL] [Abstract][Full Text] [Related]
10. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
12. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.
Sharpe A; Morley LC; Tang T; Norman RJ; Balen AH
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013505. PubMed ID: 31845767
[TBL] [Abstract][Full Text] [Related]
13. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Maheshwari A; Vaidakis D; Bhattacharya S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006606. PubMed ID: 30480769
[TBL] [Abstract][Full Text] [Related]
14. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
Al-Inany HG; Youssef MA; Ayeleke RO; Brown J; Lam WS; Broekmans FJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001750. PubMed ID: 27126581
[TBL] [Abstract][Full Text] [Related]
15. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Tang H; Mourad SM; Wang A; Zhai SD; Hart RJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD008605. PubMed ID: 33851429
[TBL] [Abstract][Full Text] [Related]
16. Volume expanders for the prevention of ovarian hyperstimulation syndrome.
Youssef MA; Mourad S
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001302. PubMed ID: 27577848
[TBL] [Abstract][Full Text] [Related]
17. Fresh versus frozen embryo transfers in assisted reproduction.
Zaat T; Zagers M; Mol F; Goddijn M; van Wely M; Mastenbroek S
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD011184. PubMed ID: 33539543
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI.
Kalampokas T; Pandian Z; Keay SD; Bhattacharya S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004752. PubMed ID: 28349525
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome.
Bordewijk EM; Ng KYB; Rakic L; Mol BWJ; Brown J; Crawford TJ; van Wely M
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD001122. PubMed ID: 32048270
[TBL] [Abstract][Full Text] [Related]
20. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Siristatidis CS; Gibreel A; Basios G; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD006919. PubMed ID: 26558801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
